SNPSTICKER
Synopsys Inc.
Congress has disclosed 18 buys and 22 sells of SNPS (Synopsys Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
18
Buy
22
Sell
-4
Net
13
Active politicians
Round-trip watch Still on the books
Members who disclosed buying SNPS and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Dan Newhouse | 2025-12-31 | $469.72 | $467.72 | -0.4% | ↩ near entry |
| Alan Armstrong | 2026-03-27 | $380.47 | $467.72 | +22.9% | in profit |
| Rohit Khanna | 2026-08-10 | $411.68 | $467.72 | +13.6% | in profit |
Price as of 2026-11-02. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Technology. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/E
83.26
▲ pricier than
Technology (median 33.7)
how it's calculated
P/E = price ÷ earnings per share
$467.72 ÷ $5.62 = 83.26
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
2.88
▼ cheaper than
Technology (median 6.2)
how it's calculated
P/B = price ÷ book value per share
$467.72 ÷ $162.56 = 2.88
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
65.67
▲ pricier than
Technology (median 21.5)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($89.6B + $6.4B net debt) ÷ $1.5B = $96.1B ÷ $1.5B = 65.67
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
Legislation Related Legislation
Recent bills in this stock's sector (Technology). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 7022 | Mystic Alerts Act | Science, Technology, Communications | 2026-10-22 |
| S 5663 | PROOF Act | Science, Technology, Communications | 2026-09-30 |
| SRES 923 | A resolution expressing support for the designation of October 4 through October 10, 2026, as "National 4-H Week". | Science, Technology, Communications | 2026-09-29 |
| HR 10610 | Stop Spam Calls Act | Science, Technology, Communications | 2026-09-24 |
| HR 10594 | Reliable Artificial Intelligence Research Act of 2026 | Science, Technology, Communications | 2026-09-24 |
42 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2026-08-10 | 22 days | +0.8% | $1K–$15K | 31.2 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2026-07-07 | 27 days | -10.2% | $1K–$15K | 19.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2026-05-01 | 38 days | -3.2% | $1K–$15K | 9.7 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Spouse | 2026-04-13 | 21 days | +19.1% | $1K–$15K | 19.3 | ↗ filing |
| Alan Armstrong | Senate | BUY | Self | 2026-03-27 | 116 days | +2.3% | $1K–$15K | 89.2 | ↗ eFD |
| Dan Newhouse | House | BUY ◆ insider divergence | Spouse · Edward Jones IRA | 2025-12-31 | 2 days | +2.3% | $1K–$15K <0.1% of NW |
66.9 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2025-12-05 | 30 days | +2.9% | $1K–$15K | 18.8 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider convergence | Self · 150 Main Street Trust > Bank of America | 2025-11-18 | 24 days | +18.0% | $1K–$15K 0.1% of NW |
27.9 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider divergence · moderate | Self · 150 Main Street Trust > Bank of America | 2025-10-09 | 34 days | -17.7% | $1K–$15K 0.1% of NW |
88.3 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider divergence · moderate | Spouse | 2025-09-25 | 10 days | -3.7% | $1K–$15K | 50.0 | ↗ filing |
| Valerie Hoyle | House | SELL ◆ insider divergence · moderate | Spouse · Fidelity Rollover IRA | 2025-09-23 | 0 days | 0.0% | $1K–$15K 0.8% of NW |
59.9 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider divergence · moderate | Spouse | 2025-09-16 | 19 days | +10.1% | $1K–$15K | 51.4 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider divergence · moderate | Spouse · Charles Schwab Brokerage Account 924 | 2025-09-11 | 20 days | +11.6% | $1K–$15K 0.1% of NW |
33.0 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider convergence · moderate | Spouse · Charles Schwab Brokerage Account 924 | 2025-08-13 | 19 days | -2.4% | $1K–$15K 0.1% of NW |
13.6 | ↗ filing |
| Julie Johnson | House | EXCHANGE | Joint · Merrill Lynch Tax Efficient Core | 2025-07-18 | 18 days | +7.5% | $1K–$15K <0.1% of NW |
62.7 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider convergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-06-09 | 65 days | +24.8% | $1K–$15K 0.1% of NW |
27.6 | ↗ filing |
| Rob Bresnahan | House | SELL ◆ insider convergence | Self · JP Morgan Brokerage Account | 2025-04-08 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
33.6 | ↗ filing |
| Jefferson Shreve | House | SELL ◆ insider convergence | Self · CRT - Standard Unit Trust | 2025-03-13 | 15 days | +2.2% | $15K–$50K <0.1% of NW |
84.7 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2025-01-22 | 13 days | -3.8% | $1K–$15K | 10.6 | ↗ filing |
| Rob Bresnahan | House | SELL ◆ insider convergence | Joint · Joint Ownership LPL Account | 2025-01-13 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
64.4 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence | Spouse · Charles Schwab Brokerage Account 548 | 2024-12-11 | 243 days | +20.3% | $1K–$15K 0.1% of NW |
63.6 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-12-09 | 29 days | -4.1% | $1K–$15K <0.1% of NW |
0.6 | ↗ filing |
| Valerie Hoyle | House | BUY | Spouse · Fidelity Rollover IRA | 2024-10-29 | 317 days | -17.2% | $1K–$15K 0.8% of NW |
65.6 | ↗ filing |
| Byron Donalds | House | SELL ◆ insider convergence | Self · Moran Wealth IRA | 2024-10-01 | 7 days | +4.5% | $1K–$15K 0.3% of NW |
67.4 | ↗ filing |
| Byron Donalds | House | SELL ◆ insider convergence | Spouse · Moran Wealth IRA | 2024-10-01 | 7 days | +4.5% | $1K–$15K 0.3% of NW |
67.4 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-09-24 | 9 days | -2.3% | $1K–$15K <0.1% of NW |
7.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-09-09 | 23 days | +7.0% | $1K–$15K | 26.5 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-08-30 | 7 days | -10.7% | $1K–$15K <0.1% of NW |
1.0 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider divergence | Spouse | 2024-08-23 | 13 days | -9.5% | $1K–$15K | 31.8 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider divergence | Spouse | 2024-08-09 | 27 days | — | $15K–$50K | 56.6 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider divergence | Spouse | 2024-08-08 | 28 days | — | $50K–$100K | 94.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-05-29 | 6 days | — | $1K–$15K | 22.3 | ↗ filing |
| Thomas Tuberville | Senate | OTHER | Joint | 2024-05-03 | 824 days | — | $1K–$15K | 75.9 | ↗ eFD |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · moderate | Child | 2024-03-25 | 9 days | — | $1K–$15K | 40.4 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider divergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-03-13 | 22 days | — | $1K–$15K <0.1% of NW |
4.1 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · moderate | Child | 2024-02-13 | 21 days | — | $1K–$15K | 75.9 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-06-22 | 14 days | — | $1K–$15K <0.1% of NW |
15.7 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2021-03-15 | 23 days | — | $1K–$15K <0.1% of NW |
31.8 | ↗ filing |
| Peter Meijer | House | SELL | Self | 2021-02-16 | 3 days | — | $1K–$15K | 86.8 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2020-06-01 | 35 days | — | $1K–$15K <0.1% of NW |
40.4 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2019-03-12 | 23 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Thomas MacArthur | House | SELL | Joint | 2015-05-27 | 5 days | — | $1K–$15K | 75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in SNPS — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
15
Congress trades with insider convergence
18
…with insider divergence
91
Insider open-market trades
Of the congressional trades in SNPS, 15 coincided with corporate insiders moving the same way within 60 days, and 18 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-10-15 | Ghazi Sassine | C-suite | SELL 10b5-1 | $6.8M | ↗ EDGAR |
| 2026-10-06 | Kankanwadi Sudhindra | C-suite | SELL | $4.6M | ↗ EDGAR |
| 2026-10-06 | LEE JANET | Other | SELL | $293K | ↗ EDGAR |
| 2026-10-06 | LEE JANET | Other | SELL | $281K | ↗ EDGAR |
| 2026-10-05 | Kankanwadi Sudhindra | C-suite | SELL | $1.5M | ↗ EDGAR |
| 2026-09-15 | Ghazi Sassine | C-suite | SELL 10b5-1 | $5.5M | ↗ EDGAR |
| 2026-09-01 | DE GEUS AART | Director | SELL 10b5-1 | $10.3M | ↗ EDGAR |
| 2026-08-31 | DE GEUS AART | Director | SELL 10b5-1 | $11.0M | ↗ EDGAR |
| 2026-08-28 | DE GEUS AART | Director | SELL 10b5-1 | $11.1M | ↗ EDGAR |
| 2026-06-15 | Ghazi Sassine | C-suite | SELL 10b5-1 | $6.7M | ↗ EDGAR |
| 2026-06-12 | Glaser Shelagh | C-suite | SELL 10b5-1 | $1.5M | ↗ EDGAR |
| 2026-01-12 | LEE JANET | Other | SELL 10b5-1 | $132K | ↗ EDGAR |
| 2026-01-07 | LEE JANET | Other | SELL 10b5-1 | $128K | ↗ EDGAR |
| 2025-12-19 | Glaser Shelagh | C-suite | SELL 10b5-1 | $481K | ↗ EDGAR |
| 2025-12-19 | Glaser Shelagh | C-suite | SELL 10b5-1 | $1.2M | ↗ EDGAR |
| 2025-09-22 | Kankanwadi Sudhindra | C-suite | SELL | $4.9M | ↗ EDGAR |
| 2025-09-19 | Kankanwadi Sudhindra | C-suite | SELL | $2.9M | ↗ EDGAR |
| 2025-09-11 | PAINTER ROBERT G | Director | BUY | $149K | ↗ EDGAR |
| 2025-09-05 | Glaser Shelagh | C-suite | SELL 10b5-1 | $1.6M | ↗ EDGAR |
| 2025-09-05 | Glaser Shelagh | C-suite | SELL 10b5-1 | $636K | ↗ EDGAR |
| 2025-09-02 | Ghazi Sassine | C-suite | SELL 10b5-1 | $6.7M | ↗ EDGAR |
| 2025-06-18 | MAHONEY RICHARD S. | C-suite | SELL 10b5-1 | $2.3M | ↗ EDGAR |
| 2025-06-18 | MAHONEY RICHARD S. | C-suite | SELL 10b5-1 | $1.4M | ↗ EDGAR |
| 2025-06-18 | MAHONEY RICHARD S. | C-suite | SELL 10b5-1 | $562K | ↗ EDGAR |
| 2025-06-06 | Glaser Shelagh | C-suite | SELL 10b5-1 | $1.0M | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-10-15 | Ghazi Sassine C-suite 10b5-1 | SELL | $6.8M |
| ◆ insider | 2026-10-06 | Kankanwadi Sudhindra C-suite | SELL | $4.6M |
| ◆ insider | 2026-10-06 | LEE JANET Other | SELL | $293K |
| ◆ insider | 2026-10-06 | LEE JANET Other | SELL | $281K |
| ◆ insider | 2026-10-05 | Kankanwadi Sudhindra C-suite | SELL | $1.5M |
| ◆ insider | 2026-09-15 | Ghazi Sassine C-suite 10b5-1 | SELL | $5.5M |
| ◆ insider | 2026-09-01 | DE GEUS AART Director 10b5-1 | SELL | $10.3M |
| ◆ insider | 2026-08-31 | DE GEUS AART Director 10b5-1 | SELL | $11.0M |
| ◆ insider | 2026-08-28 | DE GEUS AART Director 10b5-1 | SELL | $11.1M |
| Congress | 2026-08-10 | Rohit Khanna | BUY | $1K–$15K |
| Congress | 2026-07-07 | Rohit Khanna | SELL | $1K–$15K |
| ◆ insider | 2026-06-15 | Ghazi Sassine C-suite 10b5-1 | SELL | $6.7M |
| ◆ insider | 2026-06-12 | Glaser Shelagh C-suite 10b5-1 | SELL | $1.5M |
| Congress | 2026-05-01 | Rohit Khanna | BUY | $1K–$15K |
| Congress | 2026-04-13 | Rohit Khanna | BUY | $1K–$15K |
| Congress | 2026-03-27 | Alan Armstrong | BUY | $1K–$15K |
| ◆ insider | 2026-01-12 | LEE JANET Other 10b5-1 | SELL | $132K |
| ◆ insider | 2026-01-07 | LEE JANET Other 10b5-1 | SELL | $128K |
| Congress | 2025-12-31 | Dan Newhouse | BUY | $1K–$15K |
| ◆ insider | 2025-12-19 | Glaser Shelagh C-suite 10b5-1 | SELL | $481K |
| ◆ insider | 2025-12-19 | Glaser Shelagh C-suite 10b5-1 | SELL | $1.2M |
| Congress | 2025-12-05 | Rohit Khanna | BUY | $1K–$15K |
| Congress | 2025-11-18 | Gilbert Cisneros | SELL | $1K–$15K |
| Congress | 2025-10-09 | Gilbert Cisneros | SELL | $1K–$15K |
FAQ Common questions
How much has Congress traded SNPS?
18 disclosed buys and 22 sells of SNPS (Synopsys Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade SNPS?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.